From Sample to Insight: Technologies Driving the Future of Precision Oncology Assays
CRISPR-based diagnostic devices for decentralized testing: Power-Lite device prototype by Sherlock Biosciences. Image from: GEN Edge. (2022, July 20). Sherlock Biosciences Is Cracking At-Home and Field Diagnostics. Genetic Engineering & Biotechnology News. https:// www.genengnews.com/topics/coronavirus/ sherlock-biosciences-is-cracking-at-home-and-field- diagnostics/
time. This enables timely decision-making while reducing the need for in-person appointments—a trend explored further in this blog on how POCT and NGS are reshaping molecular diagnostics. Wearable and embedded technologies are also advancing decentralized care. Skin sensors can track temperature changes, digital pillcams offer noninvasive imaging, and biosensing contact lenses may soon monitor molecular markers in tear fluid. Tools like digital tattoos and contin- uous biosensors open further possibilities for passive, real-time monitoring. 17
Despite promising advances, adoption of these technologies in oncology remains limited, hindered by slow clinical uptake, limited provider awareness, and gaps in patient education. Overcoming these barriers is critical to integrating decentralized tools into mainstream cancer care. By supporting routine monitoring outside tradi- tional settings, decentralized diagnostics offer a more accessible and responsive approach to precision oncology—aligning care with patient needs and extending its reach beyond the clinic.
Conclusion: Building the Future of Cancer Diagnostics Precision oncology is entering a new era—one defined not just by advanced technologies, but by their conver- gence. AI, multi-omics, CRISPR, imaging, and decentral- ized diagnostics are no longer standalone innovations; they are interconnected tools reshaping how cancer is detected, monitored and treated.
result is a more flexible, responsive, and inclusive model of cancer care. Looking ahead, success will depend not only on scientific advancement, but on how these tools are integrated into real-world practice—balancing performance with scalability, and innovation with accessibility. As these technologies mature and align, precision oncology has the potential to deliver earlier detection, more tailored treatment decisions and broader access to care across global populations.
This evolution is enabling a shift from one-size- fits-all diagnostics to dynamic, patient-specific systems that integrate seamlessly into diverse clinical environments, including the home. The
38 | GENengnews.com
Powered by FlippingBook